Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Accuracy of robotic coil positioning during transcranial magnetic stimulation.

Goetz S, Kozyrkov IC, Luber B, Lisanby SH, Murphy DL, Grill WM, Peterchev AV.

J Neural Eng. 2019 Jun 12. doi: 10.1088/1741-2552/ab2953. [Epub ahead of print]

PMID:
31189147
2.

Multimodal analysis of formalin-fixed and paraffin-embedded tissue by MALDI imaging and fluorescence in situ hybridization for combined genetic and metabolic analysis.

Huber K, Kunzke T, Buck A, Langer R, Luber B, Feuchtinger A, Walch A.

Lab Invest. 2019 May 31. doi: 10.1038/s41374-019-0268-z. [Epub ahead of print]

PMID:
31148595
3.

Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors.

Llosa NJ, Luber B, Tam AJ, Smith KN, Siegel N, Awan AH, Fan H, Oke T, Zhang J, Domingue J, Engle EL, Roberts CA, Bartlett BR, Aulakh LK, Thompson ED, Taube JM, Durham JN, Sears CL, Le DT, Diaz LA, Pardoll DM, Wang H, Anders RA, Housseau F.

Clin Cancer Res. 2019 May 6. doi: 10.1158/1078-0432.CCR-19-0114. [Epub ahead of print]

PMID:
31061070
4.

Online repetitive transcranial magnetic stimulation during working memory in younger and older adults: A randomized within-subject comparison.

Beynel L, Davis SW, Crowell CA, Hilbig SA, Lim W, Nguyen D, Palmer H, Brito A, Peterchev AV, Luber B, Lisanby SH, Cabeza R, Appelbaum LG.

PLoS One. 2019 Mar 22;14(3):e0213707. doi: 10.1371/journal.pone.0213707. eCollection 2019.

5.

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Mar 6;7(1):63. doi: 10.1186/s40425-019-0547-7.

6.

Low- and High-Frequency Repetitive Transcranial Magnetic Stimulation Effects on Resting-State Functional Connectivity Between the Postcentral Gyrus and the Insula.

Addicott MA, Luber B, Nguyen D, Palmer H, Lisanby SH, Appelbaum LG.

Brain Connect. 2019 May;9(4):322-328. doi: 10.1089/brain.2018.0652. Epub 2019 Apr 2.

PMID:
30773890
7.

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.

Smith KN, Llosa NJ, Cottrell TR, Siegel N, Fan H, Suri P, Chan HY, Guo H, Oke T, Awan AH, Verde F, Danilova L, Anagnostou V, Tam AJ, Luber BS, Bartlett BR, Aulakh LK, Sidhom JW, Zhu Q, Sears CL, Cope L, Sharfman WH, Thompson ED, Riemer J, Marrone KA, Naidoo J, Velculescu VE, Forde PM, Vogelstein B, Kinzler KW, Papadopoulos N, Durham JN, Wang H, Le DT, Justesen S, Taube JM, Diaz LA Jr, Brahmer JR, Pardoll DM, Anders RA, Housseau F.

J Immunother Cancer. 2019 Feb 11;7(1):40. doi: 10.1186/s40425-018-0492-x. Erratum in: J Immunother Cancer. 2019 Mar 6;7(1):63.

8.

Enhancing activation in the right temporoparietal junction using theta-burst stimulation: Disambiguating between two hypotheses of top-down control of behavioral mimicry.

Duffy KA, Luber B, Adcock RA, Chartrand TL.

PLoS One. 2019 Jan 25;14(1):e0211279. doi: 10.1371/journal.pone.0211279. eCollection 2019.

9.

Complementary topology of maintenance and manipulation brain networks in working memory.

Davis SW, Crowell CA, Beynel L, Deng L, Lakhlani D, Hilbig SA, Lim W, Nguyen D, Peterchev AV, Luber BM, Lisanby SH, Appelbaum LG, Cabeza R.

Sci Rep. 2018 Dec 13;8(1):17827. doi: 10.1038/s41598-018-35887-2.

10.

The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions.

Sathappan AV, Luber BM, Lisanby SH.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:347-360. doi: 10.1016/j.pnpbp.2018.10.006. Epub 2018 Oct 9. Review.

PMID:
30312634
11.

On the Concurrent Use of Self-System Therapy and Functional Magnetic Resonance Imaging-Guided Transcranial Magnetic Stimulation as Treatment for Depression.

Neacsiu AD, Luber BM, Davis SW, Bernhardt E, Strauman TJ, Lisanby SH.

J ECT. 2018 Dec;34(4):266-273. doi: 10.1097/YCT.0000000000000545.

PMID:
30308570
12.

Excitatory TMS modulates memory representations.

Wang WC, Wing EA, Murphy DLK, Luber BM, Lisanby SH, Cabeza R, Davis SW.

Cogn Neurosci. 2018 Jul - Oct;9(3-4):151-166. doi: 10.1080/17588928.2018.1512482. Epub 2018 Sep 5.

PMID:
30124357
13.

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.

Rowe SP, Luber B, Makell M, Brothers P, Santmyer J, Schollenberger MD, Quinn H, Edelstein DL, Jones FS, Bleich KB, Sharfman WH, Lipson EJ.

Mol Oncol. 2018 Oct;12(10):1661-1672. doi: 10.1002/1878-0261.12373. Epub 2018 Sep 8.

14.

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.

Boudadi K, Suzman DL, Anagnostou V, Fu W, Luber B, Wang H, Niknafs N, White JR, Silberstein JL, Sullivan R, Dowling D, Harb R, Nirschl TR, Veeneman BA, Tomlins SA, Wang Y, Jendrisak A, Graf RP, Dittamore R, Carducci MA, Eisenberger MA, Haffner MC, Meeker AK, Eshleman JR, Luo J, Velculescu VE, Drake CG, Antonarakis ES.

Oncotarget. 2018 Jun 19;9(47):28561-28571. doi: 10.18632/oncotarget.25564. eCollection 2018 Jun 19.

15.

Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.

Antonarakis ES, Lu C, Luber B, Liang C, Wang H, Chen Y, Silberstein JL, Piana D, Lai Z, Chen Y, Isaacs WB, Luo J.

Eur Urol. 2018 Aug;74(2):218-225. doi: 10.1016/j.eururo.2018.01.035. Epub 2018 Feb 10.

PMID:
29439820
16.

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines.

Keller S, Zwingenberger G, Ebert K, Hasenauer J, Wasmuth J, Maier D, Haffner I, Schierle K, Weirich G, Luber B.

Mol Oncol. 2018 Apr;12(4):441-462. doi: 10.1002/1878-0261.12170. Epub 2018 Mar 10.

17.

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

Teply BA, Wang H, Luber B, Sullivan R, Rifkind I, Bruns A, Spitz A, DeCarli M, Sinibaldi V, Pratz CF, Lu C, Silberstein JL, Luo J, Schweizer MT, Drake CG, Carducci MA, Paller CJ, Antonarakis ES, Eisenberger MA, Denmeade SR.

Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.

18.

Differences in Seizure Expression Between Magnetic Seizure Therapy and Electroconvulsive Shock.

Cycowicz YM, Rowny SB, Luber B, Lisanby SH.

J ECT. 2018 Jun;34(2):95-103. doi: 10.1097/YCT.0000000000000470.

PMID:
29240021
19.

Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.

Keller S, Kneissl J, Grabher-Meier V, Heindl S, Hasenauer J, Maier D, Mattes J, Winter P, Luber B.

BMC Cancer. 2017 Dec 13;17(1):845. doi: 10.1186/s12885-017-3822-3.

20.

PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI.

Urban C, Buck A, Siveke JT, Lordick F, Luber B, Walch A, Aichler M.

Biochim Biophys Acta Gen Subj. 2018 Jan;1862(1):51-60. doi: 10.1016/j.bbagen.2017.10.005. Epub 2017 Oct 9.

PMID:
29024724
21.

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome.

Kunzke T, Balluff B, Feuchtinger A, Buck A, Langer R, Luber B, Lordick F, Zitzelsberger H, Aichler M, Walch A.

Oncotarget. 2017 Jul 10;8(40):68012-68025. doi: 10.18632/oncotarget.19137. eCollection 2017 Sep 15.

22.

Frequency-specific neuromodulation of local and distant connectivity in aging and episodic memory function.

Davis SW, Luber B, Murphy DLK, Lisanby SH, Cabeza R.

Hum Brain Mapp. 2017 Dec;38(12):5987-6004. doi: 10.1002/hbm.23803. Epub 2017 Sep 8.

23.

Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.

Llosa NJ, Cooke KR, Chen AR, Gamper CJ, Klein OR, Zambidis ET, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, Loeb DM, Symons HJ.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2127-2136. doi: 10.1016/j.bbmt.2017.08.012. Epub 2017 Aug 12.

25.

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr.

Science. 2017 Jul 28;357(6349):409-413. doi: 10.1126/science.aan6733. Epub 2017 Jun 8.

26.

Reprint of ''Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging-guided intervention''.

Luber BM, Davis S, Bernhardt E, Neacsiu A, Kwapil L, Lisanby SH, Strauman TJ.

Neuroimage. 2017 May 1;151:65-71. doi: 10.1016/j.neuroimage.2017.03.049.

PMID:
28476213
27.

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Zhu Y, Silberstein JL, Taylor MN, Maughan BL, Denmeade SR, Pienta KJ, Paller CJ, Carducci MA, Eisenberger MA, Luo J.

J Clin Oncol. 2017 Jul 1;35(19):2149-2156. doi: 10.1200/JCO.2016.70.1961. Epub 2017 Apr 6.

28.

Quantitation of Cancer Treatment Response by 18F-FDG PET/CT: Multicenter Assessment of Measurement Variability.

O JH, Jacene H, Luber B, Wang H, Huynh MH, Leal JP, Wahl RL.

J Nucl Med. 2017 Sep;58(9):1429-1434. doi: 10.2967/jnumed.117.189605. Epub 2017 Mar 30.

29.

Using neuroimaging to individualize TMS treatment for depression: Toward a new paradigm for imaging-guided intervention.

Luber BM, Davis S, Bernhardt E, Neacsiu A, Kwapil L, Lisanby SH, Strauman TJ.

Neuroimage. 2017 Mar 1;148:1-7. doi: 10.1016/j.neuroimage.2016.12.083. Epub 2017 Jan 3. Review.

30.

Pulse Width Affects Scalp Sensation of Transcranial Magnetic Stimulation.

Peterchev AV, Luber B, Westin GG, Lisanby SH.

Brain Stimul. 2017 Jan - Feb;10(1):99-105. doi: 10.1016/j.brs.2016.09.007. Epub 2016 Oct 6.

31.

Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.

Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, Zwingenberger G, Weichert W, Luber B.

J Cancer Res Clin Oncol. 2017 Apr;143(4):573-600. doi: 10.1007/s00432-016-2308-z. Epub 2016 Dec 8.

32.

Predicting Outcomes After Chemo-Embolization in Patients with Advanced-Stage Hepatocellular Carcinoma: An Evaluation of Different Radiologic Response Criteria.

Gunn AJ, Sheth RA, Luber B, Huynh MH, Rachamreddy NR, Kalva SP.

Cardiovasc Intervent Radiol. 2017 Jan;40(1):61-68. doi: 10.1007/s00270-016-1451-x. Epub 2016 Nov 10.

PMID:
27834009
33.

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.

Maughan BL, Suzman DL, Luber B, Wang H, Glavaris S, Hughes R, Sullivan R, Harb R, Boudadi K, Paller C, Eisenberger M, Demarzo A, Ross A, Antonarakis ES.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1297-1304. doi: 10.1007/s00280-016-3191-7. Epub 2016 Nov 8.

34.

Deriving frequency-dependent spatial patterns in MEG-derived resting state sensorimotor network: A novel multiband ICA technique.

Nugent AC, Luber B, Carver FW, Robinson SE, Coppola R, Zarate CA Jr.

Hum Brain Mapp. 2017 Feb;38(2):779-791. doi: 10.1002/hbm.23417. Epub 2016 Oct 22.

35.

Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study.

Maughan BL, Luber B, Nadal R, Antonarakis ES.

Prostate. 2017 Jan;77(1):33-40. doi: 10.1002/pros.23246. Epub 2016 Aug 16.

PMID:
27527643
36.

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.

Schweizer MT, Wang H, Luber B, Nadal R, Spitz A, Rosen DM, Cao H, Antonarakis ES, Eisenberger MA, Carducci MA, Paller C, Denmeade SR.

Prostate. 2016 Sep;76(13):1218-26. doi: 10.1002/pros.23209. Epub 2016 Jun 24.

PMID:
27338150
37.

Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.

Sadtler K, Estrellas K, Allen BW, Wolf MT, Fan H, Tam AJ, Patel CH, Luber BS, Wang H, Wagner KR, Powell JD, Housseau F, Pardoll DM, Elisseeff JH.

Science. 2016 Apr 15;352(6283):366-70. doi: 10.1126/science.aad9272.

38.

Group sequential designs with prospectively planned rules for subpopulation enrichment.

Rosenblum M, Luber B, Thompson RE, Hanley D.

Stat Med. 2016 Sep 20;35(21):3776-91. doi: 10.1002/sim.6957. Epub 2016 Apr 13.

PMID:
27076411
39.

Skilled Bimanual Training Drives Motor Cortex Plasticity in Children With Unilateral Cerebral Palsy.

Friel KM, Kuo HC, Fuller J, Ferre CL, Brandão M, Carmel JB, Bleyenheuft Y, Gowatsky JL, Stanford AD, Rowny SB, Luber B, Bassi B, Murphy DL, Lisanby SH, Gordon AM.

Neurorehabil Neural Repair. 2016 Oct;30(9):834-44. doi: 10.1177/1545968315625838. Epub 2016 Feb 11.

40.

The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer.

Teply BA, Luber B, Denmeade SR, Antonarakis ES.

Prostate Cancer Prostatic Dis. 2016 Mar;19(1):72-8. doi: 10.1038/pcan.2015.53. Epub 2015 Nov 17.

41.

Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

Hyun O J, Luber BS, Leal JP, Wang H, Bolejack V, Schuetze SM, Schwartz LH, Helman LJ, Reinke D, Baker LH, Wahl RL.

J Nucl Med. 2016 May;57(5):735-40. doi: 10.2967/jnumed.115.162412. Epub 2016 Jan 21.

42.

Enhancement of Neuromodulation with Novel Pulse Shapes Generated by Controllable Pulse Parameter Transcranial Magnetic Stimulation.

Goetz SM, Luber B, Lisanby SH, Murphy DL, Kozyrkov IC, Grill WM, Peterchev AV.

Brain Stimul. 2016 Jan-Feb;9(1):39-47. doi: 10.1016/j.brs.2015.08.013. Epub 2015 Sep 1.

43.

Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience.

Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR Jr, Herman JM.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1100-6. doi: 10.1245/s10434-015-4685-y. Epub 2015 Jul 30.

PMID:
26224402
44.

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J.

JAMA Oncol. 2015 Aug;1(5):582-91. doi: 10.1001/jamaoncol.2015.1341.

45.

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting.

Lipson EJ, Sharfman WH, Chen S, McMiller TL, Pritchard TS, Salas JT, Sartorius-Mergenthaler S, Freed I, Ravi S, Wang H, Luber B, Sproul JD, Taube JM, Pardoll DM, Topalian SL.

J Transl Med. 2015 Jul 5;13:214. doi: 10.1186/s12967-015-0572-3.

46.

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr.

N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.

47.

Associating approximate paths and temporal sequences of noisy detections: Application to the recovery of spatio-temporal cancer cell trajectories.

Dorfer M, Kazmar T, Šmíd M, Sing S, Kneißl J, Keller S, Debeir O, Luber B, Mattes J.

Med Image Anal. 2016 Jan;27:72-83. doi: 10.1016/j.media.2015.03.007. Epub 2015 Apr 29.

PMID:
25987193
48.

PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.

Rodić N, Anders RA, Eshleman JR, Lin MT, Xu H, Kim JH, Beierl K, Chen S, Luber BS, Wang H, Topalian SL, Pardoll DM, Taube JM.

Cancer Immunol Res. 2015 Feb;3(2):110-5. doi: 10.1158/2326-6066.CIR-14-0145. Epub 2014 Nov 4.

49.

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.

Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS, Zhang M, Papadopoulos N, Kinzler KW, Vogelstein B, Sears CL, Anders RA, Pardoll DM, Housseau F.

Cancer Discov. 2015 Jan;5(1):43-51. doi: 10.1158/2159-8290.CD-14-0863. Epub 2014 Oct 30.

50.

Proteomic and metabolic prediction of response to therapy in gastric cancer.

Aichler M, Luber B, Lordick F, Walch A.

World J Gastroenterol. 2014 Oct 14;20(38):13648-57. doi: 10.3748/wjg.v20.i38.13648. Review.

Supplemental Content

Support Center